Free Trial

Kindly MD (NASDAQ:KDLY) Stock Price Down 22.3% - Time to Sell?

Kindly MD logo with Medical background

Key Points

  • Shares of Kindly MD, Inc. (NASDAQ:KDLY) dropped 22.3% on Wednesday, closing at $11.09 after a significant reduction in trading volume.
  • The company's market cap is currently $66.78 million, with a P/E ratio of -14.40, indicating potential concerns about profitability.
  • Institutional investors such as Geode Capital Management have increased their stakes, with Geode acquiring an additional 8,386 shares valued at approximately $484,000.
  • Looking to export and analyze Kindly MD data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Shares of Kindly MD, Inc. (NASDAQ:KDLY - Get Free Report) fell 22.3% during trading on Wednesday . The company traded as low as $10.16 and last traded at $11.09. 1,212,564 shares changed hands during trading, a decline of 47% from the average session volume of 2,293,123 shares. The stock had previously closed at $14.28.

Kindly MD Stock Performance

The firm has a market cap of $66.78 million and a P/E ratio of -14.40. The stock's 50 day simple moving average is $12.35 and its 200 day simple moving average is $7.58.

Institutional Trading of Kindly MD

Hedge funds and other institutional investors have recently bought and sold shares of the business. Geode Capital Management LLC increased its stake in Kindly MD by 76.2% during the 2nd quarter. Geode Capital Management LLC now owns 19,394 shares of the company's stock valued at $484,000 after purchasing an additional 8,386 shares in the last quarter. Ground Swell Capital LLC bought a new stake in Kindly MD during the 4th quarter valued at $28,000. Rathbones Group PLC bought a new stake in Kindly MD during the 2nd quarter valued at $1,523,000. Finally, Cetera Investment Advisers bought a new stake in Kindly MD during the 4th quarter valued at $93,000.

Kindly MD Company Profile

(Get Free Report)

Kindly MD, Inc provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kindly MD Right Now?

Before you consider Kindly MD, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kindly MD wasn't on the list.

While Kindly MD currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines